# Effect of Intranasal Corticosteroids on Pulmonary Symptoms in Asthmatics With Nasal Congestion

> **NCT01562093** · NA · TERMINATED · sponsor: **St. Olavs Hospital** · enrollment: 14 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** corticosteroid nasal spray
- **DRUG:** placebo nasal spray

## Key facts

- **NCT ID:** NCT01562093
- **Lead sponsor:** St. Olavs Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-01
- **Primary completion:** 2016-06
- **Final completion:** 2016-06
- **Target enrollment:** 14 (ACTUAL)
- **Why stopped:** Investigational drugs no longer available
- **Last updated:** 2016-08-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01562093

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01562093, "Effect of Intranasal Corticosteroids on Pulmonary Symptoms in Asthmatics With Nasal Congestion". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01562093. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*